4-Oxadiazolyl-piperidine compounds and use thereof

Details for Australian Patent Application No. 2006314730 (hide)

Owner Purdue Pharma L.P.

Inventors Tafesse, Laykea

Agent FB Rice

Pub. Number AU-B-2006314730

PCT Pub. Number WO2007/057229

Priority 60/739,107 21.11.05 US

Filing date 21 November 2006

Wipo publication date 24 May 2007

Acceptance publication date 3 February 2011

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/454 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

12 June 2008 PCT application entered the National Phase

  PCT publication WO2007/057229 Priority application(s): WO2007/057229

3 February 2011 Application Accepted

  Published as AU-B-2006314730

2 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006314733-9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments

2006314729-A new intermediate for making montelukast and related compounds